Borkowetz A, Wullich B, Saar M, Schmidt-Hegemann N, Linxweiler J (2025)
Publication Type: Journal article
Publication year: 2025
DOI: 10.1159/000545630
Introduction: Metastasis-directed therapy (MDT) is a promising approach for recurrent or de novo oligo-metastatic castration-sensitive prostate cancer (omCSPC). The aim of this study was to evaluate the treatment approaches in omCSPC among German physicians. Methods: An anonymous online questionnaire was sent via survio.com to the members of the German Societies of Urology and Radiooncology. Results: Participants (n = 166; 33% urologists, 66% radiooncologists) define omCSPC as ≤3 (31%) or ≤4 (58%) metastases. Multimodal therapy consisting of local therapy of the primary tumor, MDT, and androgen deprivation therapy (ADT) was favored. For local therapy, radiotherapy was the preferred approach (radiotherapy: 84%, prostatectomy: 16%). Overall, 77% and 76% considered MDT as (very) highly important in synchronous and metachronous omCSPC, respectively. In total, 80% would complement MDT with time-limited ADT. Compared to urologists, radiooncologists more often include cases with ≥3 metastases (p = 0.006) and see a higher importance of radiotherapy (p = 0.023), a lower importance of prostatectomy (p < 0.001) as well as a higher importance of MDT (in de novo p = 0.038, in metachronous p = 0.010). Conclusion: MDT with time-limited ADT is a common treatment strategy in omCSPC. Especially in synchronous omCSPC, radiotherapy as local treatment for the primary is the preferred option rather than radical prostatectomy.
APA:
Borkowetz, A., Wullich, B., Saar, M., Schmidt-Hegemann, N., & Linxweiler, J. (2025). Treatment Strategies in Oligo-Metastatic Prostate Cancer: A Nationwide Survey. Urologia Internationalis. https://doi.org/10.1159/000545630
MLA:
Borkowetz, Angelika, et al. "Treatment Strategies in Oligo-Metastatic Prostate Cancer: A Nationwide Survey." Urologia Internationalis (2025).
BibTeX: Download